Drug Development News

An experimental mRNA drug has shown a breakthrough in treating deadly skin cancer, with over 8,500 Americans projected to die from melanoma this year.

A new narcolepsy drug, Orzeyful, has been developed that targets the root cause of the sleep disorder rather than just its symptoms, potentially opening doors f

The article discusses how large pharmaceutical companies like AstraZeneca and Bristol-Myers benefit from their substantial financial resources, enabling them to

GSK is set to cut jobs as part of a £1.9bn cost-cutting plan, which will fund a £400m investment in UK life sciences and a new R&D center in Cambridge. The phar

The United States is experiencing its highest number of measles cases in decades, coupled with declining vaccination rates. This surge is prompting researchers

AstraZeneca's nerve drug Wainua failed a late-stage heart disease trial, causing investor concern and a slide in the company's share price. The company's future

Biotech deals are surging to record levels as major pharmaceutical companies, driven by the fear of missing out and impending patent expirations on lucrative dr

Suven, a company with a deep innovation pipeline focused on central nervous system disorders, is nearing the final stages of its neuroscience development.